3rd Quarter - Report

IPOLICY SOLUTIONS for ASSOCIATION FOR MOLECULAR PATHOLOGY

Firm
Client
Income
$42,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act S.4348 - FDASLA Act of 2022

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor, and Pensions

Contacted: Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4128 (117th), S. 4348 (117th)

Copyright/Patent/Trademark CPT

S.4734 Patent Eligibility Restoration Act

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Legislative Fellow, Committee on Health, Education, Labor, and Pensions

Contacted: SENATE

Bills named: S. 4734 (117th)

Health Issues HCR

S.3799, PREVENT Pandemics Act Pandemic response and supply chain issues Laboratory workforce

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Health, Education, Labor and Pensions

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Office of Science & Technology Policy (OSTP)

Bills named: S. 3799 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.